ReviewExploration of targeted anti-tumor therapy2025

Future perspectives: targeting fibroblast growth factor receptor 1 to enhance the efficacy of immunotherapy.

Ilya TsimafeyeuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.